Got $5,000? These 3 growth stocks are on sale right now.

Many growth stocks have been under pressure recently as investors worry whether their valuations are too high. But buying strong growth stocks after they’ve fallen in value could set you up for some great returns—assuming, of course, that you’re willing to be patient and wait for market conditions to improve.

Three stocks that have struggled of late but can be excellent long-term investments are Celsius Holdings (CELCH 1.18%), Novo Nordisk (NGO -1.04%)and Dell Technologies (DELL -0.28%). These stocks haven’t done well in recent months, but here’s why they can be great places to put $5,000 right now.

1. Celsius Holdings

Energy drink company Celsius Holdings has generated transformational wealth for investors over the years. But in the past three months alone, the stock has lost nearly half its value as investors worried about slowing growth. While Celsius still grew at a solid 23% in its most recent quarter, which ended June 30, that’s down from the impressive 112% growth rate it achieved with a year earlier.

It would, however, be difficult to maintain such a high growth rate, especially since the company is performing better. But with Celsius still generating good numbers and expanding into more international markets while focusing on a growing sugar-free market, there’s plenty of reason to remain bullish that it can remain a growth stock top to own for years to come.

A price-to-earnings multiple of 30 isn’t terribly expensive for a stock with such rapid growth. While it may be a challenge for the company in the short term if consumers cut back on discretionary spending if a recession hits, it can still be a great investment to hold on to in the long term.

2. Novo Nordisk

Shares in healthcare company Novo Nordisk have fallen 17% over the past three months. While this isn’t a huge sell-off, getting this top growth stock at any discounted price could be a good move for investors.

Novo Nordisk is a major name in diabetes and obesity treatments. Its most famous product, Ozempic, has become a hot trend on social media in recent years. Even though it is an approved treatment for diabetes, many people have used Ozempic for weight loss.

Novo Nordisk’s approved weight-loss drug Wegovy is still in the early stages of its launch — it was approved for use in the US just over three years ago. As the company expands its capacity and launches Wegovy in more international markets, its already strong financials could look even better in the coming years. In the first half of the year, Novo Nordisk’s net sales rose 25% on a constant currency basis, totaling 133.4 billion Danish kroner ($19.7 billion).

Novo Nordisk trades at 39 times earnings, but that’s still much cheaper than its rival Eli Lillywhich trades at a multiple of over 100. Novo Nordisk is a much cheaper buy. With plenty of upside still on the horizon, it’s a fantastic stock to buy today.

3. Dell Technologies

The third promising growth stock to buy on the decline right now is Dell Technologies, which is down 14% over the past three months. I like Dell because the business is experiencing increased demand for its servers due to increased spending on artificial intelligence (AI) products and services, and there is still a huge opportunity in new AI-powered computers.

The company’s server and networking revenue rose 80 percent in its most recent quarter, which ended Aug. 2. But in the Customer Solutions Group segment, which includes personal computers (PCs), revenue fell 4 percent.

This mixed bag of results tells me Dell isn’t firing on all cylinders yet, but when it does, the stock could become a red-hot buy. AI-oriented PCs represent a big growth opportunity for Dell and other computer companies as consumers upgrade their machines to take advantage of the latest technologies. When that happens, the stock could go on a much higher trajectory.

Trading at a modest 22 times earnings, Dell is a potentially undervalued AI stock to buy right now.